Trials / Completed
CompletedNCT03688542
Opportunities and Limits to Deprescribing in Nursing Homes:Quality Circle Deprescribing Module
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Anne Niquille · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Older people residing in nursing homes (NH) are frequently polymedicated and often prescribed potentially inappropriate medications. Deprescribing has been proposed as a way to reduce the number of drugs they receive and their exposure to harmful treatments. The objectives of this study are 1) To evaluate the effect of a deprescribing-specific interdisciplinary quality circle module on the use of potentially inappropriate medication in nursing-home residents. 2) To determine the effective strategies to reach and implement deprescribing consensus resulting of said quality circle module.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Quality Circle Deprescribing Module | The Quality Circle Deprescribing Module consist of a discussion bringing together nurses, physicians and responsible pharmacist to create a local deprescribing consensus for frequently used drug classes, as well as implementation strategies for the consensus.. |
Timeline
- Start date
- 2017-09-25
- Primary completion
- 2020-07-01
- Completion
- 2020-07-01
- First posted
- 2018-09-28
- Last updated
- 2021-04-21
- Results posted
- 2021-04-21
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03688542. Inclusion in this directory is not an endorsement.